🇺🇸 FDA
Patent

US 7169594

Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

granted A61PA61P35/00A61P9/00

Quick answer

US patent 7169594 (Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00, A61P9/00, A61P9/10